174 related articles for article (PubMed ID: 32365965)
1. Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity.
Gupte M; Umbarkar P; Singh AP; Zhang Q; Tousif S; Lal H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365965
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
Gupte M; Tumuluru S; Sui JY; Singh AP; Umbarkar P; Parikh SS; Ahmad F; Zhang Q; Force T; Lal H
Int J Cardiol; 2018 May; 259():145-152. PubMed ID: 29398139
[TBL] [Abstract][Full Text] [Related]
3. Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance.
Gupte M; Tousif S; Lemon JJ; Toro Cora A; Umbarkar P; Lal H
Cells; 2022 Feb; 11(3):. PubMed ID: 35159367
[TBL] [Abstract][Full Text] [Related]
4. Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3β.
Wohua Z; Weiming X
Biomed Pharmacother; 2019 Oct; 118():108940. PubMed ID: 31382130
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
Sampath C; Srinivasan S; Freeman ML; Gangula PR
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G481-G493. PubMed ID: 32812777
[TBL] [Abstract][Full Text] [Related]
7. Protein
Wang SB; Venkatraman V; Crowgey EL; Liu T; Fu Z; Holewinski R; Ranek M; Kass DA; O'Rourke B; Van Eyk JE
Circ Res; 2018 May; 122(11):1517-1531. PubMed ID: 29563102
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte-GSK-3β deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms.
Yusuf AM; Qaisar R; Al-Tamimi AO; Jayakumar MN; Woodgett JR; Koch WJ; Ahmad F
J Cell Physiol; 2022 Mar; 237(3):1804-1817. PubMed ID: 34812500
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
12. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
Cho J; Zhai P; Maejima Y; Sadoshima J
Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
[TBL] [Abstract][Full Text] [Related]
13. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
15. Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.
Zhou J; Ahmad F; Parikh S; Hoffman NE; Rajan S; Verma VK; Song J; Yuan A; Shanmughapriya S; Guo Y; Gao E; Koch W; Woodgett JR; Madesh M; Kishore R; Lal H; Force T
Circ Res; 2016 Apr; 118(8):1208-22. PubMed ID: 26976650
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity.
Li Z; Zhu H; Liu C; Wang Y; Wang D; Liu H; Cao W; Hu Y; Lin Q; Tong C; Lu M; Sachinidis A; Li L; Peng L
J Cell Mol Med; 2019 Nov; 23(11):7796-7809. PubMed ID: 31503410
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β heterozygous knockout is cardioprotective in a knockin mouse model of familial dilated cardiomyopathy.
Mohamed RM; Morimoto S; Ibrahim IA; Zhan DY; Du CK; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1808-15. PubMed ID: 27106044
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism.
Theeuwes WF; Gosker HR; Langen RCJ; Verhees KJP; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3075-3086. PubMed ID: 28943449
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
